Local Institution

Vaxjo 352 34

0 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Atrial Flutter, Melanoma, Prostate Cancer, Prostatic Neoplasms

Studies at this site

• Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants — Withdrawn before enrolling
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer — Completed
• Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
• Phase III Acute Coronary Syndrome — Stopped early